Ozempic vs Wegovy vs Mounjaro vs Zepbound vs Retatrutide vs CagriSema: 2026 Complete Guide to GLP-1 Peptides for Weight Loss & How to Preserve Muscle
Table of Contents
The GLP-1 & Multi-Agonist Boom in 2026: What You Really Need to Know
In early 2026, GLP-1 receptor agonists and next-gen multi-agonists dominate conversations about sustainable weight loss. Originally developed for type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) now deliver 15-22% average body weight reduction in trials when combined with lifestyle changes. Emerging options push even further: retatrutide hit 28.7% average loss (~71 lbs) in the TRIUMPH-4 Phase 3 trial (Dec 2025 readout), while CagriSema showed 14.2% loss and superior HbA1c reduction vs semaglutide in REIMAGINE 2 (Feb 2026).
These medications work by mimicking gut hormones: suppressing appetite via brain signals, slowing gastric emptying for prolonged fullness, improving insulin sensitivity, and—in triple agonists—boosting energy expenditure. The result? Significant fat loss, better metabolic health, and often reduced obesity-related complications like knee pain (seen with retatrutide).
But here’s the fitness reality: rapid weight loss without protection can erode 25-40% of lost weight as lean mass (muscle + water + organ tissue), per STEP and SURMOUNT trial subsets. This lowers resting metabolism, risks sarcopenia (especially in older adults), and can make regain easier. Recent case series and ongoing trials (e.g., NCT06885736) show that resistance training 3-5x/week + high protein (1.6-2.2 g/kg/day) can minimize loss—or even increase lean mass—during treatment.
At ProhealthLink, we focus on quality recomposition: drop fat, keep or build muscle. Below is the 2026 breakdown, with real data, visuals, and actionable steps.
Disclaimer: This is educational—not medical advice. These are prescription medications. Consult a physician before starting or combining with exercise/nutrition. Results vary; meds + lifestyle yield best outcomes.
(Alt: “Ozempic semaglutide injection pen close-up 2026”)
How These Medications Work (Mechanisms Explained)
- Single GLP-1 agonists (semaglutide): Target GLP-1 receptors → appetite ↓, gastric emptying ↓, insulin ↑, glucagon ↓.
- Dual GLP-1/GIP (tirzepatide): Adds GIP for stronger satiety and metabolic effects.
- Triple GLP-1/GIP/glucagon (retatrutide): Glucagon increases energy burn.
- GLP-1 + amylin analog (CagriSema): Amylin enhances fullness and complements semaglutide.
No plateau in many CagriSema participants at 68 weeks—suggesting continued potential.
Current & Emerging Options: 2026 Comparison
Ozempic (Semaglutide)
Weekly injection (up to 2 mg), primarily diabetes-approved; off-label weight loss common. Average: 10-15% loss.
Official prescribing info: Ozempic.com
(Alt: “Ozempic injection pen macro close-up”)
Wegovy (Higher-Dose Semaglutide)
Up to 2.4 mg weekly for chronic weight management. ~15% average loss (STEP trials). Oral daily pill launched 2026 improves access.
Official site: Wegovy.com
Mounjaro / Zepbound (Tirzepatide)
Dual agonist. SURMOUNT-5 head-to-head: 20.2% vs Wegovy’s 13.7%. Zepbound for weight/sleep apnea.
Official site: Zepbound.lilly.com
(Alt: “Zepbound tirzepatide injection pen in use”)
Retatrutide (Eli Lilly Triple Agonist)
TRIUMPH-4 Phase 3 (Dec 2025): 28.7% average loss at 12 mg over 68 weeks (~71 lbs), plus knee osteoarthritis pain relief (74-76% reduction). Filing expected 2026.
CagriSema (Novo Nordisk)
REIMAGINE 2 (Feb 2026): 14.2% loss & superior HbA1c vs semaglutide’s 10.2%. REDEFINE 1: up to 22.7% in obesity. FDA filing Dec 2025; review 2026.
Quick Comparison Table (Trial Averages, ~68 Weeks):
- Semaglutide (Wegovy/Ozempic): 13-15%
- Tirzepatide (Zepbound/Mounjaro): 15-22% (up to 25% long-term)
- CagriSema: 14-23% (superior to semaglutide)
- Retatrutide: 24-29% (highest recorded)
Real-world often lower without diet/exercise. Regain common if discontinued (~back to baseline in 1-2 years).
The Muscle Loss Reality & How to Fight It
Trials show 25-40% of lost weight as lean mass (e.g., STEP ~40% for semaglutide; SURMOUNT ~26% for tirzepatide). Older adults/women at higher risk.
2025-2026 evidence:
- Case series: Patients with resistance training + high protein preserved/increased lean mass (+2.5% to +5.8% in some).
- Ongoing trial (NCT06885736): Testing resistance exercise + 1.6 g/kg protein during semaglutide/tirzepatide.
- Strategies: Resistance training counters catabolism; protein (especially leucine-rich) supports synthesis.
(Alt: “Dumbbell squats and deadlifts for muscle preservation during GLP-1 weight loss”)
Proven Muscle Preservation Plan
- Resistance Training 3-5x/Week Progressive full-body or split: squats, deadlifts, presses, rows. Start 3 sets of 8-12 reps. Track overload.
- High Protein Intake 1.6-2.2 g/kg body weight (or ideal/fat-free mass). 30-50 g/meal. Sources: chicken, eggs, Greek yogurt, whey, fish. Spread evenly; leucine ≥3 g/meal.
(Alt: “High-protein chicken quinoa bowl with veggies for muscle support on peptides”)
- Calorie & Recovery Balance Mild deficit (500 kcal/day). Sleep 7-9 hrs. Include mobility/walking.
- Tracking Use DXA/photos/measurements/strength logs—not just scale.
(Alt: “Before/after body composition showing fat loss with muscle preservation”)
Side Effects & Long-Term Considerations
Common (transient): Nausea, vomiting, diarrhea, constipation. Mitigate: slow titration, small meals.
Serious (rare): Pancreatitis, gallbladder issues, thyroid tumors (rodent warning). GI effects can reduce workout energy—start low-intensity.
Long-term: Regain risk high if stopped; monitor bone/muscle density.
Sample Weekly Integration Plan
- Mon/Wed/Fri: Strength circuit (squats, push-ups, rows) + 40 g protein post-workout.
- Tue/Thu: Mobility/walking + high-protein meals.
- Weekend: Active recovery + meal prep.
FAQ
Which is strongest in 2026? Retatrutide leads trials (up to 29%); tirzepatide outperforms semaglutide now. More muscle loss on one vs another? Similar proportions; faster loss increases absolute risk—training mitigates. Can I gain muscle on these? Yes—with protein surplus on training days. What if I stop? Regain likely without habits; taper + maintain strength.
Your 2026 ProhealthLink Action Plan
- Get physician approval.
- Start resistance training 3-5x/week.
- Hit 1.6-2.2 g/kg protein daily.
- Track body comp & strength.
- Treat meds as a tool—consistency builds permanence.
What are your goals with these medications or recomposition? Comment below or reach out for personalized guidance!
CTA: Subscribe for weekly evidence-based tips. Explore: Home Strength Workouts | High-Protein Meal Ideas